-
Biotech Most Active – Exelixis, Inc. (NASDAQ:EXEL), Gilead Sciences, Inc. (NASDAQ:GILD), Galena Biopharma Inc (NASDAQ:GALE), Cell Therapeutics Inc (NASDAQ:CTIC)
Exelixis, Inc. (NASDAQ:EXEL) said Thursday that it has priced its overnight underwritten public offering of 10 million shares of newly issued common stock at a price to the public of $8.00 per share. Shares of Exelixis, Inc. (EXEL) closed at $8.01 in last trading session. Yesterday share price of the company was traded in the…
-
Top Gainers Healthcare – BG Medicine (NASDAQ:BGMD), Cell Therapeutics (NASDAQ:CTIC), Synta Pharmaceuticals (NASDAQ:SNTA), Idera Pharmaceuticals (NASDAQ:IDRA)
BG Medicine, Inc. (NASDAQ:BGMD) skyrocketed 31.32% as the final determination of the 2014 Medicare national limitation amount for the company’s galectin-3 blood test at the amount of a crosswalked test whose 2014 national limitation amount is $30.01 was set to apply effective January 1, 2014. Moreover, the 2014 national limitation amount is subject to a…
-
Biotech Most Active – Gilead Sciences (NASDAQ:GILD), Cell Therapeutics Inc (NASDAQ:CTIC), Galena Biopharma Inc (NASDAQ:GALE), Ariad Pharmaceuticals (NASDAQ:ARIA)
Gilead Sciences, Inc. (NASDAQ:GILD) had a very successful 2013 driven by its strong product portfolio. The biopharmaceutical company ended the year on a high with its blockbuster hopeful, Sovaldi, gaining U.S. approval for treating patients suffering from chronic hepatitis C virus (HCV). Shares of Gilead Sciences, Inc. (NASDAQ:GILD) closed at $75.21 in last trading session.…
-
Key Biotech Event Today – (QCOR, CTIC, ARNA, VVUS)
Governor John Kitzhaber recently declared Tuesday, Oct. 9, 2012, as “Oregon Digital Health and Bioscience Day,” opening Oregon’s biggest bioscience conference ever, with symposia, networking, poster sessions, and thought-leadership debate on the local and growth of the bioscience industry across the globe. The two-day Oregon Bio 2012 at Marylhurst University was predicted to attract up…
-
U.S. and India Sign a MoU to Co-operate in the Field of Biotechnology – (CTIC, QCOR, GILD, ACAD)
The US-based Washington Biotechnology and Biomedical Association (WBBA) and the Association of Biotechnology Led Enterprises (ABLE), a consortium of Indian biotechnology companies, have reportedly signed a memorandum of understanding (MoU) with an aim to enable broad ranging co-operation in the field of biotechnology. The tie-up is expected to support breakthrough discoveries in different field including…
-
Investors Now Paying More Attention to the anti-obesity Drug Market – (ARNA, ARQL, GILD, ILMN, CTIC, VVUS)
Shares of firms developing or marketing anti-obesity drugs, such as Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and VIVUS, Inc. (NASDAQ:VVUS) both edged up yesterday, have gathered more attention from investors this year as two weight loss drugs have successfully gained approval from the U.S. Food and Drug Administration, the first approvals in over 13 years. Roche Holdings…
-
The Biopharma Industry Across Massachusetts Adds Record Jobs, Contributes $6B in State Payroll – (CUR, PSTI, ARNA, CTIC)
The number of people hired in the biopharma industry across Massachusetts, where the average maximum salary is $113,000, increased 1 percent as compared to last year to hit best level ever of above 53,000, according to a report released yesterday by the MassBio. The industry trade association report disclosed that the industry’s expansion trend continued…
-
The Biotechnology Industry Now Needs New Ways To Maintain Success – (ARNA, CTIC, GILD, PPHM)
Technology is playing a key role in changing the world, and the bioscience and healthcare industries are no omission, according to a biotechnology supporter and venture capitalist who spoke in a conference held in Madison yesterday. G. Steven Burrill, who is a UW-Madison graduate and was among the featured speakers at the daylong 2012 Bioscience…
-
Timid Political Will Stops New Zealand From Becoming A Global Leader In Biotechnology –(CTIC, SNSS, PPHM, ZLCS)
Farming leader-scientist Dr Williams Rolleston says that timid political will is preventing New Zealand from growing to be a global leader in biotechnology. As scientists took steps to feed billions of more humans, opportunities existed for the nation to prove leadership in biotechnology, without causing environmental degradation. Cell Therapeutics Inc. (NASDAQ:CTIC) rose around 40% after…
-
Major Pharma/Biotech Companies To Benefit From Personalized Medicine – (ARNA, CTIC, SVNT, GALE)
A report on key facts of the personalized medicine industry and its impact on the health system revealed that individualized or personalized medicine plans to boost the value of therapeutics via genetic testing and companion diagnostics. Personalized therapeutics and associated companion diagnostics are expected to be more specific and effective thus giving pharma/biotech companies a…